Welcome to our dedicated page for SGFY news (Ticker: SGFY), a resource for investors and traders seeking the latest updates and insights on SGFY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SGFY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SGFY's position in the market.
Signify Health (NYSE: SGFY) will announce its Q3 2021 financial results on November 9, 2021, post-market. A conference call is scheduled for November 10, 2021, at 8:30 AM ET to discuss the results. Pre-registration is necessary for call participation, and access details will be sent via email. A live webcast will also be available on the company's investor relations website, with a replay accessible until January 10, 2022. Signify Health focuses on value-based healthcare solutions, enhancing patient outcomes and cost-efficiency through advanced analytics and nationwide provider networks.
Signify Health (NYSE: SGFY) has announced a strategic partnership with HealthComp, aimed at providing self-funded employer groups with more affordable health benefits packages. This collaboration focuses on integrating value-based payments with value-based benefits design, aiming to enhance clinical outcomes and reduce healthcare costs. Employers are increasingly implementing value-based insurance designs (VBID) to align the use of high-value services with provider accountability. The partnership will launch in select U.S. markets, emphasizing transparency and affordability.
GoodCell has appointed Chris Garcia as its new CEO, effective immediately, succeeding founder Trevor Perry, who transitions to President. Garcia aims to enhance the company's commercial strategy, R&D initiatives, and platform for member engagement. He comes with over 30 years of healthcare experience, most recently leading Remedy Partners. The company has recently completed financing rounds and formed key partnerships with organizations like Quest and the New York Blood Center, positioning GoodCell to accelerate its market rollout in personal biobanking and genetic health monitoring.
Signify Health (NYSE: SGFY) announced the appointment of Arnold Goldberg to its board of directors, serving on the audit committee. Goldberg, previously with PayPal, brings extensive experience in platform architecture and product strategy. His arrival aligns with Signify's mission to drive value-based healthcare transformation. CEO Kyle Armbrester highlighted Goldberg's leadership capability and the potential to enhance technology platforms. This strategic addition aims to improve care outcomes and foster long-term growth in healthcare services.
Signify Health (SGFY) reported strong financial results for Q2 2021, with total revenue increasing by 63% to $212.8 million, driven by robust Home & Community Services (HCS) revenue of $175.4 million, a 109% year-over-year rise. However, Episodes of Care Services (ECS) revenue fell 20% to $37.4 million due to COVID-19 impacts. The company posted a net loss of $0.1 million, contrasting with a net income of $7 million from last year. Full-year guidance for total revenue is revised to $745 million to $765 million.
Signify Health (NYSE: SGFY) has launched its Transition to Home solution in over 50 hospitals, aimed at supporting Medicare patients transitioning from hospital to home. This initiative addresses avoidable readmissions, costing Medicare approximately $17 billion annually. The solution provides coordinated clinical and social care for up to 90 days post-discharge, utilizing a team of care coordinators, pharmacists, and nurses. Early results indicate over 60% patient engagement, suggesting a significant reduction in rehospitalization rates.
Signify Health (NYSE: SGFY) has appointed Sam Pettijohn as Chief Growth Officer and Erin Kelly as Chief Compliance Officer. Pettijohn, formerly of Cerner Corporation, will enhance client engagement and support market expansion. Kelly will focus on developing compliance policies, leveraging her extensive regulatory experience from CVS Health/Aetna. These appointments align with the company's aim to drive sustainable growth in value-based healthcare through improved client relations and compliance management.
Signify Health, Inc. (NYSE: SGFY) will release its second quarter 2021 financial results after market close on August 10, 2021, followed by a conference call at 8:30 a.m. ET on August 11, 2021. Pre-registration is required for call participation, and details will be provided via email upon registration. A live webcast of the call will be available on Signify Health's investor relations website, with a replay accessible until October 11, 2021. The company aims to transform healthcare delivery through value-based payment programs supported by advanced analytics and a nationwide provider network.
Signify Health (SGFY) and Humana (HUM) collaborate with the Alamo Area Community Network (AACN) to enhance resources for Humana Medicare Advantage members in San Antonio. This initiative focuses on connecting members with essential services like food, transportation, and financial aid, thus supporting Humana's six-year Bold Goal journey to tackle health-related social needs. The AACN comprises over 40 organizations committed to addressing social determinants of health (SDOH). Their cooperative efforts aim to closely integrate clinical and social health services.
FAQ